Opioids and Low Testosterone: What Men Should Know
Our Team
10/22/2026
If you take a prescription opioid and notice changes in sexual interest, erections, or energy, your medication history belongs in a medical evaluation. Opioids can contribute to low testosterone, but taking one does not establish the diagnosis or automatically make testosterone replacement therapy the next step.
A useful evaluation connects symptoms, appropriately timed testing, and the treatment you already receive. The aim is to understand what is contributing to the problem while keeping your pain care and hormone care coordinated.
Opioids are one possible contributor
The MedlinePlus overview of male hypogonadism lists opioid pain medicines among possible medication-related causes of reduced testosterone production. Other medicines, testicular conditions, obesity, and other health problems can also contribute.
That matters when interpreting a result. A low value during opioid treatment does not prove the medicine is the only cause. Bring the full picture to your clinician rather than assuming that every symptom comes from testosterone or that a new hormone prescription will resolve it.
Describe symptoms and when they changed
The FDA warning about opioids and sex hormones identifies reduced sexual interest, erectile problems, and infertility as reasons to tell a healthcare professional. It recommends laboratory evaluation when relevant symptoms or signs are present.
Explain when the change began, whether it preceded opioid treatment, and whether it appeared around a medication change. Describe what is most disruptive rather than using only a general label such as “low T.” FDA also noted limitations in the evidence: illness, stress, weight changes, and other medicines can complicate attribution to opioids.
Confirm the diagnosis before discussing a prescription
The Endocrine Society's current diagnosis statement emphasizes symptoms together with consistently low, accurately measured testosterone. It calls for at least two early-morning, fasting testosterone measurements. Symptoms alone are insufficient.
Bring previous reports, including collection dates and times. Ask whether the results are comparable and whether another measurement is needed. An isolated number, an online questionnaire, or the fact that you use an opioid should not substitute for a clinician's interpretation of the findings.
Testing timing deserves a separate discussion
A short course after an operation is a different situation from ongoing treatment for chronic pain. The Endocrine Society clinical guideline advises against testing men for testosterone deficiency during or while recovering from acute illness, or during short-term use of medicines such as opioids that suppress testosterone.
Tell the clinician whether your situation is temporary, ongoing, or changing. Ask when testing would be meaningful. This is a reason to plan the assessment with your treating team, not to skip a prescribed medicine to try to obtain a different laboratory result.
What the original testosterone trial found
An original randomized trial in opioid-related testosterone deficiency studied 84 men aged 18–64 taking opioids for chronic noncancer pain. Participants had low testosterone and received testosterone gel or placebo for 14 weeks; 65 provided follow-up efficacy data.
Testosterone improved selected experimentally measured pain-sensitivity outcomes, sexual desire, and body composition compared with placebo. However, changes in self-reported clinical pain did not differ between groups. A response to a controlled laboratory pain stimulus is not the same outcome as relief of a patient's ongoing pain.
This small, short study does not establish testosterone as a pain treatment or predict every patient's response. Its findings should not be turned into a promise of fewer pain medicines or long-term safety.
Do not change an opioid on your own
Concern about hormones is a reason to contact the prescriber. It is not a reason to abruptly stop an opioid, skip doses, or substitute another medicine yourself. FDA guidance on safe opioid prescribing warns against abrupt discontinuation and emphasizes individual clinical judgment and communication about pain control.
If a medication review is appropriate, ask the prescribing team what options exist and how any change would be supervised. Keep the hormone clinician informed. A plan made with one clinician should not unintentionally conflict with instructions from another.
Make the medication history useful
Prepare a current list of prescription medicines, nonprescription products, supplements, and any hormone treatment. Include the reason each medicine was prescribed, how long you have used it, and the actual instructions you follow. Bring the packaging or a current medication list if names are difficult to remember.
Also identify who manages each prescription. These details give the clinician something concrete to review and make it easier to request relevant records. You do not need to decide which medicine is responsible before asking for help.
Agree on a plan for reviewing the findings
Ask what the evaluation has established, what remains uncertain, and whether another assessment is needed before deciding about TRT. If treatment is proposed, discuss the intended benefit, individual risks, alternatives, and how progress would be assessed. A plan should address your specific concern rather than only changing a laboratory number.
Clarify who will review repeat results and communicate with the opioid prescriber. Ask when to follow up and how to share changes in symptoms or prescriptions between visits. Keep copies of the agreed instructions so the next conversation starts with the same information.
Frequently asked questions
Does taking an opioid mean I need TRT?
No. Opioids are a possible contributor, not a diagnosis or an automatic indication for treatment. Symptoms, testing, other potential causes, and an individual benefit-and-risk discussion still matter.
Can TRT replace pain treatment or reduce my opioid needs?
The cited trial did not show better self-reported pain relief than placebo. It does not establish TRT as a substitute for pain treatment or support a promise of needing less opioid medication.
Should I skip my opioid before a testosterone test?
Do not change the prescription yourself. Tell the clinician what you take and ask how your medication use and current health affect the timing and interpretation of testing.
Will testosterone recover if my medication changes?
A normal result or a recovery deadline cannot be promised. The underlying cause and follow-up findings need review. Any medication change should be clinician-directed, with a plan for reassessing the concern.
Discuss your history through California telehealth
Men in Los Angeles and elsewhere in California can review SoCal Testosterone Clinic's testosterone-replacement information and contact the practice about a telehealth consultation. California-only telehealth is available now, with no in-person clinic appointments. Ask how to share your medication history and previous results; separate local examination or testing may be necessary.
Recent Posts
Opioids and Low Testosterone: What Men Should Know
Learn how opioids can affect testosterone, why test timing matters, and what to discuss with your prescriber before making treatment changes.
Peptide Medicines and Allergic Reactions: Warning Signs
Know allergy warning signs after a peptide medicine, how intolerance differs, and which symptoms need emergency help.
Oral Peptides vs. Injections: Why Formulation Matters
Learn why oral peptides, injections, and compounded preparations need evidence for the exact product, formulation, and route.